Status | 已發表Published |
Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy | |
Zhu, L.; Liu, J.; Zhou, G.; Liu, T.; Dai, Y.; Nie, G.; Zhao, Q. | |
2021-08-01 | |
Source Publication | Small |
ISSN | 1613-6829 |
Pages | 2102624-2102624 |
Abstract | Targeting B7-H3 chimeric antigen receptor (CAR) T cells has antitumor potential for therapy of non-small cell lung cancer (NSCLC) in preclinical studies. However, CAR T cell therapy remains a formidable challenge for the treatment of solid tumors due to the heterogeneous and immunosuppressive tumor microenvironment (TME). Nanozymes exhibit merits modulating the immunosuppression of the tumor milieu. Here, a synergetic strategy by combination of nanozymes and CAR T cells in solid tumors is described. This nanozyme with dual photothermal-nanocatalytic properties is endowed to remodel TME by destroying its compact structure. It is found that the B7-H3 CAR T cells infused in mice engrafted with the NSCLC cells have superior antitumor activity after nanozyme ablation of the tumor. Importantly, it is found that the changes altered immune-hostile cancer environment, resulting in enhanced activation and infiltration of B7-H3 CAR T cells. The first evidence that the process of combination nanozyme therapy effectively improves the therapeutic index of CAR T cells is presented. Thus, this study clearly supports that the TME-immunomodulated nanozyme is a promising tool to improve the therapeutic obstacles of CAR T cells against solid tumors. |
Keyword | B7-H3 immune checkpoint chimeric antigen receptor T cell immunotherapy nanozyme photothermal-nanocatalytic effect |
URL | View the original |
Language | 英語English |
The Source to Article | PB_Publication |
PUB ID | 61522 |
Document Type | Journal article |
Collection | DEPARTMENT OF PUBLIC HEALTH AND MEDICINAL ADMINISTRATION |
Corresponding Author | Zhao, Q. |
Recommended Citation GB/T 7714 | Zhu, L.,Liu, J.,Zhou, G.,et al. Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy[J]. Small, 2021, 2102624-2102624. |
APA | Zhu, L.., Liu, J.., Zhou, G.., Liu, T.., Dai, Y.., Nie, G.., & Zhao, Q. (2021). Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy. Small, 2102624-2102624. |
MLA | Zhu, L.,et al."Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy".Small (2021):2102624-2102624. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment